GHRH and neoplasm: The absence of expression of GHRH and its receptors in PC-3 tumours after combined treatment may suggest that the observed reduction in tumour growth is a consequence of the modification of the molecular machinery involved in the processes of tumourigenesis, angiogenesis, and metastasis.